FDA approval given to Perrigo The U.S. Food and Drug Administration recently granted approval to Perrigo Company for its abbreviated new drug application for morphine sulfate oral solution.

Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over the counter and generic prescription pharmaceuticals, infant formula, nutritional products and active pharmaceutical ingredients.

Perrigo is planning to start shipping the product immediately, which is a controlled substance used for the relief of moderate to severe acute and chronic pain when the use of an apioid analgesic is appropriate.

According to Wolters Kluwer Health, generic annual sales are approximately $26 million.

"This approval is a testament to our continued commitment to bring new specialized products to market," said Joseph Papa, Perrigo's chairman, president and CEO. "We continue to focus on our mission of making healthcare more accessible and affordable for consumers."

Talon Therapeutics was also recently granted approval from the FDA for blood cancer treatment, which could make the company's supply chain process busier in the coming months.
Share To:

Strategic Sourceror

Post A Comment:

0 comments so far,add yours